Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis.
Schistosoma haematobium
Africa
bladder cancer
squamous cell carcinoma
transitional cell carcinoma
Journal
International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Titre abrégé: Int J Urol
Pays: Australia
ID NLM: 9440237
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
03
04
2018
accepted:
11
09
2018
pubmed:
23
10
2018
medline:
5
6
2019
entrez:
23
10
2018
Statut:
ppublish
Résumé
To quantify the epidemiology of bladder cancer in Africa to guide a targeted public health response and support research initiatives. We systematically searched publicly available sources for population-based registry studies reporting the incidence of bladder cancer in Africa between January 1980 and June 2017. Crude incidence rates of bladder cancer were extracted. A Bayesian network meta-analysis model was used to estimate incidence rates. The search returned 1328 studies. A total of 22 studies carried out across 15 African countries met our pre-defined selection criteria. Heterogeneity across studies was high (I The present study suggests a growing incidence of bladder cancer in Africa in recent years, particularly among men and in North Africa. This study also highlights the lack of quality data sources and collection of essential clinical and epidemiological data in several African countries, and this hinders public health planning.
Identifiants
pubmed: 30345565
doi: 10.1111/iju.13824
pmc: PMC6409482
mid: NIHMS1005249
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102-112Subventions
Organisme : NHLBI NIH HHS
ID : K99 HL141678
Pays : United States
Informations de copyright
© 2018 The Japanese Urological Association.
Références
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Cancer Causes Control. 2008 May;19(4):421-9
pubmed: 18188671
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
Semin Oncol. 2001 Apr;28(2):174-8
pubmed: 11301380
Eur Urol. 2016 Feb;69(2):300-10
pubmed: 26346676
BMC Med. 2014 Dec 18;12:243
pubmed: 25518855
JAMA. 2014 Jan 8;311(2):183-92
pubmed: 24399557
Urol Oncol. 2012 Jan-Feb;30(1):81-8
pubmed: 22127016
J Stat Softw. 2017;76:
pubmed: 36568334
Int J Cancer. 2015 Nov 1;137(9):2060-71
pubmed: 26135522
Int J Cancer. 2001 Oct 15;94(2):153-6
pubmed: 11668491
Can J Urol. 2008 Feb;15(1):3899-908
pubmed: 18304401
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Braz J Infect Dis. 2015 Mar-Apr;19(2):196-205
pubmed: 25636189
JAMA Oncol. 2017 Apr 01;3(4):524-548
pubmed: 27918777
Eur Urol. 2014 Jul;66(1):59-73
pubmed: 24451595
IARC Sci Publ. 2003;(153):1-414
pubmed: 14570050
Cancer Epidemiol. 2009 Oct;33(3-4):176-81
pubmed: 19762298
Int J Cancer. 2010 Dec 15;127(12):2893-917
pubmed: 21351269
J Glob Health. 2018 Jun;8(1):010419
pubmed: 29740502